A randomized phase II trial assessing in advanced non-small cell lung cancer patients with stable disease after two courses of cisplatin-gemcitabine an early modification of chemotherapy doublet with paclitaxel-gemcitabine versus …(GFPC 03-01 study)

[ppt]J Thorac Oncol 2009_4-364-70 (634 Ko)[/ppt]